Items Tagged ‘OptumLabs’
February 8, 2021
Mayo Clinic Research in the news — 2/8/2021
In the week’s news, you can find expertise from Mayo Clinic clinicians and researchers on a range of topics, including several different heart conditions, a blood test for Alzheimer’s, cancer, disparities in diabetes care, and of course COVID-19. Expertise from a Mayo Clinic International consultant is also highlighted, along with Michael Camilleri, M.D., who received […]
Tags: Alzheimer's disease, artificial intelligence, Bart Demaerschalk, blood cancer, blood disease, blood test, breast cancer, cardiology, cardiovascular disease, caregivers, Center for Digital Health, Center for the Science of Health Care Delivery
February 2, 2021
Diabetes treatment disparities widespread, room for improvement
More than 34 million people in the U.S. have diabetes, reports the Centers for Disease Control and Prevention. Of these, the vast majority have type 2, or a reduced ability of their bodies to effectively process sugar in foods into energy for life. Most people with type 2 diabetes have multiple considerations – including heart […]
Tags: Centers for Disease Control and Prevention, diabetes, health care value, health disparities, health equity, heart disease, hypoglycemia, kidney disease, medication management, OptumLabs, pharmacy, Rozalina McCoy
March 3, 2020
Research News Roundup–February 2020
Each month, we publish Mayo Clinic’s Research News Roundup. This article includes brief summaries and links to news releases from the preceding month that discuss some of our latest medical research and/or research education. It also connects readers to related resources. Read on for recent findings of Mayo Clinic Research: Florida State University and Mayo Clinic […]
Tags: Amir Lerman, artificial intelligence, biomedical research, cardiovascular disease, cardiovascular medicine, COPD, diabetes, education, Florida State University, heart disease, Mayo Clinic Proceedings, medical research education
September 20, 2019
Good news about the effectiveness of antifibrotics for IPF
In a recent study published in the American Journal of Respiratory and Critical Care, a research team led by Andrew Limper, M.D., a pulmonology and critical care physician at Mayo Clinic, evaluated the effectiveness of pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. The researchers reported “the medications had an association with a reduced […]
Tags: Andrew Limper, Center for the Science of Health Care Delivery, clinical trials, idiopathic pulmonary fibrosis, OptumLabs
September 13, 2019
REAL WORLD EVIDENCE in health care improvement
In late 2012 Optum and Mayo Clinic came together to form OptumLabs, an open, collaborative research and innovation center, dedicated to improving patient care and patient value through data-driven health care research, leading-edge data science and strong partner collaboration. Since that time, approximately 150 collaborative projects have led to peer-reviewed publication, a critical step towards […]
Tags: atrial fibrillation, big data, Center for the Science of Health Care Delivery, clinical trials, OptumLabs, research
August 5, 2019
Blood thinners in combination increase bleeding risk, Mayo study finds
Gastrointestinal bleeding is a common side effect for many blood-thinning medications. But new Mayo Clinic research finds that risk is amplified when patients receive more than one blood thinner – especially if they’re 75 or older. The study, published in Clinical Gastroenterology and Hepatology, found patients receiving an anticoagulant drug and an antiplatelet drug, in […]
Tags: AHRQ, anticoagulant, antiplatelet, blood thinner, Center for the Science of Health Care Delivery, Che Ngufor, gastroenterology, Neena Abraham, Nilay Shah, OptumLabs, Peter Noseworthy, Xiaoxi Yao
April 3, 2019
Research News Roundup-March 2019
The Mayo Clinic Research News Roundup includes brief summaries and links to research news releases from the past month. It also connects readers to related resources. Read on for more information from Mayo Clinic Research. Removal of ‘zombie cells’ alleviates causes of diabetes in obese mice Mayo Clinic researchers and their collaborators have shown that when senescent […]
Tags: AFib, aging, Alzheimer's disease, atrial fibrillation, biomarkers, cancer, Center for the Science of Health Care Delivery, clinical trials, diabetes, gastroenterology, hepatitis, JAMA
November 13, 2018
On the Front Lines of Anaphylaxis: Using Data to Save Lives
By Advancing the Science contributor 
By Ronna Campbell, M.D., Ph.D.; Megan Motosue, M.D.; and M. Fernanda Bellolio, M.D.; Mayo Clinic Anaphylaxis is a serious, potentially life-threatening allergic reaction that affects millions of Americans. Today, nearly 15 million people in the U.S. have a food allergy and numbers are increasing. Symptoms of anaphylaxis can occur within seconds following exposure to an allergen such […]
Tags: anaphylaxis, Center for the Science of Health Care Delivery, emergency department, emergency medicine, M. Fernanda Bellolio, Megan Motosue, OptumLabs, Ronna Campbell
September 13, 2018
The rising tide of nonalcoholic fatty liver disease
Liver disease? Me? I don’t drink. I don’t smoke. Okay, so I don’t exercise that much, and where did all these candy bar wrappers come from? Anyway, I thought liver disease was just for alcoholics? These are question many Americans ask when diagnosed with nonalcoholic fatty liver disease. But as its name implies, NAFLD is […]
Tags: Alina Allen, Center for the Science of Health Care Delivery, OptumLabs, Rochester Epidemiology Project
July 11, 2018
Breast cancer survivors are not getting the recommended level of post-surgery screening, according to a study published in the May 2018 issue of the Journal of the National Comprehensive Cancer Network (JNCCN). Contrary to screening recommendations, mammography rates decline over time as women get further out from their breast cancer diagnosis; African-American women in particular […]
Tags: breast cancer, Center for the Science of Health Care Delivery, Kathryn Ruddy, Mayo Clinic Cancer Center, OptumLabs, women's health